Dr Horton, Inc. (DHI)

$186.14

+2.42

(+1.32%)▲

Market is closed - opens 7 PM, 09 Sep 2024

Performance

  • $184.38
    $188.81
    $186.14
    downward going graph

    0.95%

    Downside

    Day's Volatility :2.34%

    Upside

    1.41%

    downward going graph
  • $100.08
    $193.63
    $186.14
    downward going graph

    46.23%

    Downside

    52 Weeks Volatility :48.31%

    Upside

    3.87%

    downward going graph

Returns

PeriodDr Horton, Inc.Sector (Consumer Discretionary)S&P500
3 Months
32.75%
2.7%
1.1%
6 Months
19.86%
0.8%
4.9%
1 Year
58.94%
8.1%
21.5%
3 Years
98.46%
-0.9%
19.7%

Highlights

Market Capitalization
60.7B
Book Value
$75.32
Dividend Share
1.15
Dividend Yield
0.65%
Earnings Per Share (EPS)
15.06
PE Ratio
12.36
PEG Ratio
0.62
Wall Street Target Price
188.09
Profit Margin
13.36%
Operating Margin TTM
17.66%
Return On Assets TTM
11.92%
Return On Equity TTM
21.31%
Revenue TTM
37.3B
Revenue Per Share TTM
112.26
Quarterly Revenue Growth YOY
2.5%
Gross Profit TTM
8.9B
EBITDA
6.5B
Diluted Eps TTM
15.06
Quarterly Earnings Growth YOY
0.05
EPS Estimate Current Year
14.57
EPS Estimate Next Year
15.97
EPS Estimate Current Quarter
3.75
EPS Estimate Next Quarter
4.1

Analyst Recommendation

Buy
    66%Buy
    25%Hold
    7%Sell
Based on 27 Wall street analysts offering stock ratings for Dr Horton, Inc.(by analysts ranked 0 to 5 stars)
Based on 27 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
18
18
18
Hold
7
9
9
Sell
2
1
1

Analyst Forecast

What analysts predicted

Upside of 1.05%

Current $186.14
Target $188.09

Company Financials

FY18Y/Y Change
Revenue
16.1B
↑ 14.03%
Net Income
1.5B
↑ 40.63%
Net Profit Margin
9.09%
↑ 1.72%
FY19Y/Y Change
Revenue
17.6B
↑ 9.49%
Net Income
1.6B
↑ 10.83%
Net Profit Margin
9.2%
↑ 0.11%
FY20Y/Y Change
Revenue
20.3B
↑ 15.45%
Net Income
2.4B
↑ 46.66%
Net Profit Margin
11.69%
↑ 2.49%
FY21Y/Y Change
Revenue
27.8B
↑ 36.74%
Net Income
4.2B
↑ 75.92%
Net Profit Margin
15.03%
↑ 3.34%
FY22Y/Y Change
Revenue
33.5B
↑ 20.54%
Net Income
5.9B
↑ 40.27%
Net Profit Margin
17.5%
↑ 2.47%
FY23Y/Y Change
Revenue
35.5B
↑ 5.92%
Net Income
4.7B
↓ 18.98%
Net Profit Margin
13.38%
↓ 4.12%
Q1 FY23Q/Q Change
Revenue
8.0B
↑ 9.85%
Net Income
942.2M
↓ 1.72%
Net Profit Margin
11.82%
↓ 1.39%
Q2 FY23Q/Q Change
Revenue
9.7B
↑ 21.98%
Net Income
1.3B
↑ 41.7%
Net Profit Margin
13.73%
↑ 1.91%
Q3 FY23Q/Q Change
Revenue
10.5B
↑ 8.0%
Net Income
1.5B
↑ 13.08%
Net Profit Margin
14.37%
↑ 0.64%
Q4 FY23Q/Q Change
Revenue
7.7B
↓ 26.45%
Net Income
947.4M
↓ 37.25%
Net Profit Margin
12.26%
↓ 2.11%
Q1 FY24Q/Q Change
Revenue
9.1B
↑ 17.88%
Net Income
1.2B
↑ 23.72%
Net Profit Margin
12.87%
↑ 0.61%
Q2 FY24Q/Q Change
Revenue
10.0B
↑ 9.43%
Net Income
1.4B
↑ 15.49%
Net Profit Margin
13.58%
↑ 0.71%
FY18Y/Y Change
Total Assets
14.1B
↑ 15.84%
Total Liabilities
5.0B
↑ 11.69%
FY19Y/Y Change
Total Assets
15.6B
↑ 10.57%
Total Liabilities
5.3B
↑ 7.18%
FY20Y/Y Change
Total Assets
18.9B
↑ 21.18%
Total Liabilities
6.8B
↑ 27.85%
FY21Y/Y Change
Total Assets
24.0B
↑ 26.99%
Total Liabilities
8.8B
↑ 29.58%
FY22Y/Y Change
Total Assets
30.4B
↑ 26.38%
Total Liabilities
10.6B
↑ 20.07%
FY23Y/Y Change
Total Assets
32.6B
↑ 7.35%
Total Liabilities
9.4B
↓ 10.61%
Q1 FY23Q/Q Change
Total Assets
31.2B
↑ 2.99%
Total Liabilities
10.0B
↑ 3.47%
Q2 FY23Q/Q Change
Total Assets
32.3B
↑ 3.7%
Total Liabilities
10.2B
↑ 1.91%
Q3 FY23Q/Q Change
Total Assets
32.6B
↑ 0.8%
Total Liabilities
9.4B
↓ 7.78%
Q4 FY23Q/Q Change
Total Assets
33.4B
↑ 2.45%
Total Liabilities
9.8B
↑ 3.53%
Q1 FY24Q/Q Change
Total Assets
34.4B
↑ 3.05%
Total Liabilities
10.1B
↑ 3.31%
Q2 FY24Q/Q Change
Total Assets
35.2B
↑ 2.19%
Total Liabilities
10.0B
↓ 1.0%
FY18Y/Y Change
Operating Cash Flow
545.2M
↑ 25.3%
Investing Cash Flow
2.6M
↓ 101.52%
Financing Cash Flow
-82.5M
↓ 85.25%
FY19Y/Y Change
Operating Cash Flow
892.1M
↑ 63.63%
Investing Cash Flow
-394.0M
↓ 15253.85%
Financing Cash Flow
-490.1M
↑ 494.06%
FY20Y/Y Change
Operating Cash Flow
1.4B
↑ 59.35%
Investing Cash Flow
-166.1M
↓ 57.84%
Financing Cash Flow
270.6M
↓ 155.21%
FY21Y/Y Change
Operating Cash Flow
534.4M
↓ 62.41%
Investing Cash Flow
-252.2M
↑ 51.84%
Financing Cash Flow
-85.1M
↓ 131.45%
FY22Y/Y Change
Operating Cash Flow
561.8M
↑ 5.13%
Investing Cash Flow
-414.9M
↑ 64.51%
Financing Cash Flow
-811.2M
↑ 853.23%
FY23Y/Y Change
Operating Cash Flow
4.3B
↑ 666.13%
Investing Cash Flow
-310.2M
↓ 25.23%
Financing Cash Flow
-2.7B
↑ 228.74%
Q1 FY23Q/Q Change
Operating Cash Flow
644.5M
↓ 22.27%
Investing Cash Flow
-37.7M
↓ 73.62%
Financing Cash Flow
-144.7M
↓ 77.62%
Q2 FY23Q/Q Change
Operating Cash Flow
787.5M
↑ 22.19%
Investing Cash Flow
-308.5M
↑ 718.3%
Financing Cash Flow
-326.2M
↑ 125.43%
Q3 FY23Q/Q Change
Operating Cash Flow
2.0B
↑ 159.43%
Investing Cash Flow
-310.2M
↑ 0.55%
Financing Cash Flow
-1.5B
↑ 374.92%

Technicals Summary

Sell

Neutral

Buy

Dr Horton, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Dr Horton, Inc.
Dr Horton, Inc.
10.14%
19.86%
58.94%
98.46%
274.0%
Nvr, Inc.
Nvr, Inc.
9.72%
18.04%
41.57%
77.74%
140.78%
Pultegroup, Inc.
Pultegroup, Inc.
8.52%
14.41%
60.78%
146.97%
274.57%
Lennar Corp.
Lennar Corp.
7.6%
9.12%
51.95%
71.91%
242.14%
Toll Brothers Inc.
Toll Brothers Inc.
11.85%
15.52%
69.29%
118.62%
281.58%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Dr Horton, Inc.
Dr Horton, Inc.
12.36
12.36
0.62
14.57
0.21
0.12
0.01
75.32
Nvr, Inc.
Nvr, Inc.
18.73
18.73
4.89
499.16
0.4
0.2
NA
1337.72
Pultegroup, Inc.
Pultegroup, Inc.
9.8
9.8
0.33
13.4
0.27
0.14
0.01
53.98
Lennar Corp.
Lennar Corp.
12.12
12.12
1.31
14.31
0.16
0.09
0.01
97.88
Toll Brothers Inc.
Toll Brothers Inc.
9.51
9.51
0.94
14.7
0.22
0.1
0.01
73.46
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Dr Horton, Inc.
Dr Horton, Inc.
Buy
$60.7B
274.0%
12.36
13.36%
Nvr, Inc.
Nvr, Inc.
Buy
$27.9B
140.78%
18.73
16.18%
Pultegroup, Inc.
Pultegroup, Inc.
Buy
$27.0B
274.57%
9.8
16.75%
Lennar Corp.
Lennar Corp.
Buy
$48.4B
242.14%
12.12
11.58%
Toll Brothers Inc.
Toll Brothers Inc.
Buy
$14.0B
281.58%
9.51
14.63%

Insights on Dr Horton, Inc.

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 7.72B → 9.96B (in $), with an average increase of 11.9% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 947.4M → 1.35B (in $), with an average increase of 16.3% per quarter

  • Vs TOL

    In the last 1 year, Toll Brothers Inc. has given 69.3% return, outperforming this stock by 10.4%

  • Vs PHM

    In the last 3 years, Pultegroup, Inc. has given 118.6% return, outperforming this stock by 20.1%

Institutional Holdings

  • Vanguard Group Inc

    10.62%

  • BlackRock Inc

    10.45%

  • State Street Corporation

    4.14%

  • Capital World Investors

    4.03%

  • JPMorgan Chase & Co

    3.52%

  • Capital Research Global Investors

    3.52%

Corporate Announcements

  • Dr Horton, Inc. Dividends March,2024

    In the quarter ending March,2024. Dr Horton, Inc. has declared dividend of $0.3

    Read More

Company Information

d.r. horton - america's builder d.r. horton is dedicated to building quality crafted, distinctive homes across the united states. the company has developed a reputation for high quality homes with features and amenities other builders often consider options or upgrades. the flexible home designs, attention to detail and affordable pricing are what make d.r. horton a national leader in the residential home building industry. donald r. horton began his own construction business in 1978 in the dallas/fort worth metroplex. in 1987, d.r. horton began expanding its operations by seeking out the nation's most active homebuilding markets. additionally, d.r. horton provides mortgage and title insurance services in many of its markets.

Organization
Dr Horton, Inc.
Employees
13450
CEO
Mr. David V. Auld
Industry
Consumer Durables

Discover More

FAQs